Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM study.
Folprecht G, Pericay C, Saunders MP, Thomas A, Lopez Lopez R, Roh JK, Chistyakov V, Höhler T, Kim JS, Hofheinz RD, Ackland SP, Swinson D, Kopp M, Udovitsa D, Hall M, Iveson T, Vogel A, Zalcberg JR. Folprecht G, et al. Ann Oncol. 2016 Jul;27(7):1273-9. doi: 10.1093/annonc/mdw176. Epub 2016 Apr 18. Ann Oncol. 2016. PMID: 27091810 Free article. Clinical Trial.
[New therapy options in colorectal carcinoma].
Folprecht G, Köhne CH. Folprecht G, et al. Ther Umsch. 2004 Jun;61(6):373-8. doi: 10.1024/0040-5930.61.6.373. Ther Umsch. 2004. PMID: 15253162 Review. German.
Role of new agents in the treatment of colorectal cancer.
Köhne CH, Bruce C, Folprecht G, Audisio R. Köhne CH, et al. Among authors: folprecht g. Surg Oncol. 2004 Aug-Nov;13(2-3):75-81. doi: 10.1016/j.suronc.2004.09.004. Surg Oncol. 2004. PMID: 15572089 Review.
152 results